Scientists continue to explore several options to treat SARS-CoV-2 infection with hundreds of therapeutics at various phases of development. At the start of the pandemic, several factors hampered the rapid identification of potential SARS-CoV-2 therapeutics, including a limited understanding of the infection mechanism of the virus and the host immune response.
Read this literature review to learn how scientists utilized non-invasive in vivo bioluminescence imaging to study SARS-CoV-2 progression and host immune response, as well as evaluating the efficacy of various antiviral strategies.